MedPath

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Phase 2
Completed
Conditions
Esophageal Cancer
Gastric Cancer
Interventions
Registration Number
NCT00012363
Lead Sponsor
SWOG Cancer Research Network
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or recurrent cancer of the esophagus.

Detailed Description

OBJECTIVES:

* Determine the 6-month survival rate of patients with metastatic or recurrent carcinoma of the esophagus or gastroesophageal junction treated with gemcitabine and irinotecan.

* Determine the qualitative and quantitative toxic effects of this regimen in these patients.

OUTLINE: Patients receive gemcitabine IV over 30 minutes and irinotecan IV over 90 minutes on days 1 and 8. Treatment repeats every 21 days for at least 6 courses in the absence of disease progression or unacceptable toxicity.

Patients are followed every 3 months for 1 year and then every 6 months for 2 years.

PROJECTED ACCRUAL: A total of 30-55 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Gemcitabine + Irinotecangemcitabine hydrochlorideGemcitabine 1000mg/m2 IV over 30 min on Days 1,8 q21days; Irinotecan 100mg/m2 IV over 90 min on Days 1,8 q21days
Gemcitabine + Irinotecanirinotecan hydrochlorideGemcitabine 1000mg/m2 IV over 30 min on Days 1,8 q21days; Irinotecan 100mg/m2 IV over 90 min on Days 1,8 q21days
Primary Outcome Measures
NameTimeMethod
6-month survival rate6 months after registration

To assess the six-month survival rate in patients with esophageal cancer treated with a gemcitabine-irinotecan combination chemotherapy regimen.

Secondary Outcome Measures
NameTimeMethod
ToxicitiesWeek 1 and Week 2 of each cycle

To assess the qualitative and quantitative toxicities associated with this regimen in a Phase II study.

Trial Locations

Locations (96)

CCOP - Atlanta Regional

🇺🇸

Atlanta, Georgia, United States

Jonsson Comprehensive Cancer Center, UCLA

🇺🇸

Los Angeles, California, United States

Veterans Affairs Outpatient Clinic - Martinez

🇺🇸

Martinez, California, United States

CCOP - Beaumont

🇺🇸

Royal Oak, Michigan, United States

Providence Hospital - Southfield

🇺🇸

Southfield, Michigan, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Veterans Affairs Medical Center - Jackson

🇺🇸

Jackson, Mississippi, United States

CCOP - Dayton

🇺🇸

Kettering, Ohio, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

Cleveland Clinic Taussig Cancer Center

🇺🇸

Cleveland, Ohio, United States

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

University of Texas - MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

Veterans Affairs Medical Center - Houston

🇺🇸

Houston, Texas, United States

CCOP - Virginia Mason Research Center

🇺🇸

Seattle, Washington, United States

Swedish Cancer Institute

🇺🇸

Seattle, Washington, United States

Veterans Affairs Medical Center - Seattle

🇺🇸

Seattle, Washington, United States

Veterans Affairs Medical Center - Salt Lake City

🇺🇸

Salt Lake City, Utah, United States

Huntsman Cancer Institute

🇺🇸

Salt Lake City, Utah, United States

Veterans Affairs Medical Center - Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Barrett Cancer Center, The University Hospital

🇺🇸

Cincinnati, Ohio, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

Veterans Affairs Medical Center - San Antonio (Murphy)

🇺🇸

San Antonio, Texas, United States

City of Hope Comprehensive Cancer Center

🇺🇸

Duarte, California, United States

Cancer Research Center of Hawaii

🇺🇸

Honolulu, Hawaii, United States

MBCCOP - Gulf Coast

🇺🇸

Mobile, Alabama, United States

Tripler Army Medical Center

🇺🇸

Honolulu, Hawaii, United States

CCOP - Santa Rosa Memorial Hospital

🇺🇸

Santa Rosa, California, United States

David Grant Medical Center

🇺🇸

Travis Air Force Base, California, United States

USC/Norris Comprehensive Cancer Center and Hospital

🇺🇸

Los Angeles, California, United States

Veterans Affairs Medical Center - Chicago (Westside Hospital)

🇺🇸

Chicago, Illinois, United States

Louisiana State University Health Sciences Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Arizona Cancer Center

🇺🇸

Tucson, Arizona, United States

Chao Family Comprehensive Cancer Center

🇺🇸

Orange, California, United States

Veterans Affairs Medical Center - Wichita

🇺🇸

Wichita, Kansas, United States

Veterans Affairs Medical Center - West Los Angeles

🇺🇸

Los Angeles, California, United States

Veterans Affairs Medical Center - Tucson

🇺🇸

Tucson, Arizona, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

Tulane University School of Medicine

🇺🇸

New Orleans, Louisiana, United States

CCOP - Central Illinois

🇺🇸

Decatur, Illinois, United States

Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

St. Louis University Health Sciences Center

🇺🇸

Saint Louis, Missouri, United States

CCOP - Cancer Research for the Ozarks

🇺🇸

Springfield, Missouri, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Veterans Affairs Medical Center - Albuquerque

🇺🇸

Albuquerque, New Mexico, United States

Veterans Affairs Medical Center - Dayton

🇺🇸

Dayton, Ohio, United States

Veterans Affairs Medical Center - Charleston

🇺🇸

Charleston, South Carolina, United States

Veterans Affairs Medical Center - Little Rock (McClellan)

🇺🇸

Little Rock, Arkansas, United States

CCOP - Bay Area Tumor Institute

🇺🇸

Oakland, California, United States

MBCCOP-Howard University Cancer Center

🇺🇸

Washington, District of Columbia, United States

Dwight David Eisenhower Army Medical Center

🇺🇸

Fort Gordon, Georgia, United States

MBCCOP - University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)

🇺🇸

Hines, Illinois, United States

Veterans Affairs Medical Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Veterans Affairs Medical Center - Lexington

🇺🇸

Lexington, Kentucky, United States

Albert B. Chandler Medical Center, University of Kentucky

🇺🇸

Lexington, Kentucky, United States

MBCCOP - LSU Health Sciences Center

🇺🇸

New Orleans, Louisiana, United States

Veterans Affairs Medical Center - Boston (Jamaica Plain)

🇺🇸

Jamaica Plain, Massachusetts, United States

CCOP - Grand Rapids Clinical Oncology Program

🇺🇸

Grand Rapids, Michigan, United States

Veterans Affairs Medical Center - Biloxi

🇺🇸

Biloxi, Mississippi, United States

CCOP - Duluth

🇺🇸

Duluth, Minnesota, United States

Keesler Medical Center - Keesler AFB

🇺🇸

Keesler AFB, Mississippi, United States

Veterans Affairs Medical Center - Kansas City

🇺🇸

Kansas City, Missouri, United States

CCOP - St. Louis-Cape Girardeau

🇺🇸

Saint Louis, Missouri, United States

CCOP - Kansas City

🇺🇸

Kansas City, Missouri, United States

Veterans Affairs Medical Center - Albany

🇺🇸

Albany, New York, United States

MBCCOP - University of New Mexico HSC

🇺🇸

Albuquerque, New Mexico, United States

Herbert Irving Comprehensive Cancer Center

🇺🇸

New York, New York, United States

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

CCOP - Columbus

🇺🇸

Columbus, Ohio, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Brooke Army Medical Center

🇺🇸

Fort Sam Houston, Texas, United States

CCOP - Greenville

🇺🇸

Greenville, South Carolina, United States

Veterans Affairs Medical Center - Temple

🇺🇸

Temple, Texas, United States

CCOP - Scott and White Hospital

🇺🇸

Temple, Texas, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

Madigan Army Medical Center

🇺🇸

Tacoma, Washington, United States

CCOP - Greater Phoenix

🇺🇸

Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)

🇺🇸

Phoenix, Arizona, United States

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

University of Colorado Cancer Center

🇺🇸

Denver, Colorado, United States

Veterans Affairs Medical Center - Denver

🇺🇸

Denver, Colorado, United States

Veterans Affairs Medical Center - Ann Arbor

🇺🇸

Ann Arbor, Michigan, United States

CCOP - Ann Arbor Regional

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

Barbara Ann Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

Veterans Affairs Medical Center - Detroit

🇺🇸

Detroit, Michigan, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

CCOP - Southeast Cancer Control Consortium

🇺🇸

Winston-Salem, North Carolina, United States

Veterans Affairs Medical Center - Oklahoma City

🇺🇸

Oklahoma City, Oklahoma, United States

Veterans Affairs Medical Center - Portland

🇺🇸

Portland, Oregon, United States

Oklahoma Medical Research Foundation

🇺🇸

Oklahoma City, Oklahoma, United States

CCOP - Columbia River Program

🇺🇸

Portland, Oregon, United States

OHSU Cancer Institute

🇺🇸

Portland, Oregon, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath